Constantine Balotis

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Venues

Blood

This page only lists publications with an associated author ORCID identifier.

Publications

Sridhar Chaganti, Shanna Maycock, Graham McIlroy, Aimee Jackson, Rebecca Bishop, Sarah Johnson, Edward Kanfer, Shireen Kassam, Kate Cwynarski, David Wrench, Arvind Arumainathan, Christopher P Fox, Rod Johnson, Pamela McKay, Shankara Paneesha, Clare Rowntree, Constantine Balotis, Graham P Collins, Andrew John Davies, Josh Wright, Sarah Burns, Arian Dominic John Laurence, Keith Wheatley, Tobias Menne
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial. Blood 144 (4) (2024)
Sridhar Chaganti, Shanna Maycock, Graham McIlroy, Aimee E Jackson, Rebecca Bishop, Sarah Johnson, Edward Kanfer, Shireen Kassam, Kate Cwynarski, David J Wrench, Arvind Arumainathan, Christopher P Fox, Rod J Johnson, Pamela McKay, Shankara Paneesha, Clare Rowntree, Constantine Balotis, Graham P Collins, Andrew John Davies, Josh Wright, Sarah Burns, Arian Dominic John Laurence, Keith Wheatley, Tobias Menne
Ibrutinib as part of risk-stratified treatment for post-transplant lymphoproliferative disorder: The phase 2 TIDaL trial. Blood (2024)
Sridhar Chaganti, Shanna Maycock, Graham McIlroy, Aimee Jackson, Rebecca Bishop, Sarah Johnson, Edward Kanfer, Shireen Kassam, Kate Cwynarski, David Wrench, Arvind Arumainathan, Christopher P Fox, Rod Johnson, Pamela McKay, Shankara Paneesha, Clare Rowntree, Constantine Balotis, Graham P Collins, Andrew John Davies, Josh Wright, Sarah Burns, Arian Dominic John Laurence, Keith Wheatley, Tobias Menne
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial. Blood 144 (4) (2024)

Constantine Balotis.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Constantine Balotis